Celera Corporation (NASDAQ:CRA) reported the appointment of Alfred Merriweather as Senior Vice President and Chief Financial Officer of the Company, effective immediately. In this position, Mr. Merriweather will provide leadership to the Celera finance, investor relations and information technology functions, and will report to Kathy Ordoñez, Celera’s Chief Executive Officer.
Celera Corporation offers personalized disease management through a combination of products and services primarily in the United States. The company’s Lab Services segment provides a portfolio of clinical laboratory tests and disease management services designed to help physicians improve cardiovascular disease treatment regimens for their patients.
Power3 Medical Products, Inc. (PWRM.OB) delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii.
To date, Power3 Medical Products, Inc. has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Amyotrophic lateral sclerosis is a form of motor neuron disease. ALS is a progressive, fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement. The condition is often called Lou Gehrig's disease in North America, after the famous New York Yankees baseball player who was diagnosed with the disease in 1939.
PWRM has filed several patent applications for its NuroPro technology that are currently pending.
Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. The tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
For more information about this company please visit http://www.power3medical.com
PowerSecure International, Inc. (NASDAQ:POWR) has received $10 million of new awards for utility infrastructure projects, driven by an award to serve a top U.S. investor-owned utility in a newly established relationship with the Company’s UtilityServices business unit. The majority of the $10 million in expected new revenue is to provide this major utility with construction and maintenance services for its electrical transmission system in 2011. Additionally, the new awards include distribution system upgrade projects for a municipality in the Midwest, and a wastewater treatment system in Texas.
PowerSecure International, Inc. provides energy and smart grid solutions, and energy services. The company’s Energy and Smart Grid Solutions segment’s products and services include Interactive Distributed Generation power systems; smart grid monitoring for electric utilities; peak shaving and demand response; standby power dispatch and control; and switchgear products and systems under the NexGear brand name.
Orofino Gold Corp. (ORFG.PK) -Three of the hottest metals in terms of price and demand are gold, silver and copper. Current reports indicate that this trend is likely to continue. Although copper demand had fallen off due to the economic slump worldwide, demand is starting to rise.
Rather than buying these metals as commodities, savvy investors can invest in a company that intends to mine all three of these metals in Columbia. ORFG has plans to mine gold along with silver and copper at properties it has acquired in Columbia, the new hot spot for gold mining.
Orofino Gold believes that the area it will be mining will result in more than a million ounces of gold and large amounts of silver and copper as well. If the company is right, this could be a homerun for investors.
Orofino Gold Corp. is an International gold company focused on the acquisition, exploration and development of gold properties in Mexico and Colombia. The company has reviewed several bulk minable properties and has signed an option to acquire properties in the Sur de Bolivar Department of Colombia South America.
For more information about this company please visit http://www.orofinogold.com
Stewardship Financial Corp. (NASDAQ:SSFN) has declared a $0.05 per share cash dividend. Common stockholders of record as of January 14, 2011 will be paid the dividend on February 1, 2011. In announcing the dividend, Chairman William C. Hanse stated, "We are pleased to continue to recognize our shareholders with this dividend. The board remains diligent in monitoring the Corporation's dividends during these uncertain economic times."
Stewardship Financial Corporation operates as the holding company for Atlantic Stewardship Bank that provides commercial and retail banking services to small and medium sized businesses and individuals in Bergen, Morris, and Passaic counties, New Jersey.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).